Inflammatory Bowel Disease Inflammatory Bowel Disease Drug Pathway – Including Addendum 1-8 Janus Kinase (JAK) Inhibitors and MHRA Safety Warnings Sequential interleukin (IL) inhibitor – Proposal for use
